Skip to content
Hemodia

Hemodia

MedTech·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Hemodia?

Hemodia is currently owned by LBO France through LBO France Small Cap (2020 vintage), since 2025. Across its history, Hemodia has been through 4 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

LBO France
Most recent investor
LBO France
LBO France Small Cap · 2020 · Buyout
4 ownership periods · full history below

Key facts

HQFrance
SectorMedTech
Key takeaways
  • ·Co-held by Multicroissance, Africinvest Europe and LBO France since 2022.
  • ·4 distinct PE sponsors across ownership cycles.

Ownership history

4 ownership periods · co-invest detected

Active
Co-held by Multicroissance, Africinvest Europe and LBO France since 2022.
Co-invest · 4 holders · 2019 · present
iXO Private Equity
2019 · 2025(6yr) · FIP APL 2015 · 2015 · Evergreen
Secondary · to
MOIC
Africinvest Europe
2022 · present(4yr) · Fonds Franco-Africain II (FFA2) · 2020 · Growth
Multicroissance
2022 · present(4yr) · Multicroissance SAS SCR · 1991 · Growth
LBO France
2025 · present(1yr) · LBO France Small Cap · 2020 · Buyout
Track Hemodia

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Hemodia?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Hemodia.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue